Tempus AI launched "Preview," an AI-powered application for precision oncology. The tool shortens the time between ordering diagnostic tests and receiving definitive results.
It delivers preliminary, clinically significant insights to clinicians. These insights arrive within approximately 24 hours of a lab receiving a tissue sample. This addresses the waiting period when clinicians often make treatment decisions with incomplete information.
At launch, Preview predicts key biomarkers. These include EGFR mutations in non-small cell lung cancer. They also include microsatellite instability (MSI-H) in colorectal, prostate, and other cancers.
These early insights help care teams make informed decisions and accelerate personalized treatment.